Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
Clinical trial NCT05734066 · RECRUITING
Trial details
- NCT number
- NCT05734066
- Sponsor
- Jazz Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-23
- Primary completion
- 2028-01-28
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.